SLC2A1 and prostate carcinoma: GLUT overexpression in prostate cancer and other tumors is well studied, and an elevated expression of hypoxia-inducible factor 1 leads to the expression of GLUT1 and GLUT3 that upregulate glucose uptake and drives glucose to the glycolytic pathway [14,15].